CommentaryUntangling a Role for Tau in Synucleinopathies
Section snippets
Acknowledgments and Disclosures
The authors report no biomedical financial interests or potential conflicts of interest.
References (10)
- et al.
Pathological interface between oligomeric alpha-synuclein and tau in synucleinopathies
Biol Psychiatry
(2015) - et al.
Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease
Acta Neuropathol
(2008) - et al.
Lewy body pathology is a frequent co-pathology in familial Alzheimer’s disease
Acta Neuropathol
(2003) - et al.
Alpha-synuclein and tau: Teammates in neurodegeneration?
Mol Neurodegener
(2014) - et al.
Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease
Ann Hum Genet
(2010)
There are more references available in the full text version of this article.
Cited by (2)
Investigating key factors underlying neurodegeneration linked to alpha-synuclein spread
2022, Neuropathology and Applied NeurobiologyA rapid, semi-quantitative assay to screen for modulators of Alpha-synuclein oligomerization ex vivo
2016, Frontiers in Neuroscience
- 1
MD and SM contributed equally to this work.
Copyright © 2015 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.